Home / Research / Manufacturers / BioMerieux SA Medical-device intelligence
BioMerieux SA: FDA clearances and recalls Research BioMerieux SA in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
Names and coverage This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
Names observed in the source
Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.
Product codes in this company’s records Record activity in this scope 0 clearance records and 46 recall records in the covered releases, across 1 source company names and 20 product codes. Dated history runs from Apr 17, 2013 to Sep 11, 2026.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 0 0 November 2025 0 0 December 2025 0 0 January 2026 0 0 February 2026 0 0 March 2026 0 0 April 2026 0 0 May 2026 0 0 June 2026 0 0 July 2026 0 0 August 2026 0 0 September 2026 0 1 October 2026 0 0
Product codes represented Code and FDA device name Clearances Recalls JWY · Manual Antimicrobial Susceptibility Test Systems 0 18 LIB · Device, General Purpose, Microbiology, Diagnostic 0 5 PPM · General Purpose Reagent 0 5 LON · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation 0 2 CGJ · Radioimmunoassay, Follicle-Stimulating Hormone 0 1 CHP · Radioimmunoassay, Estradiol 0 1 DAP · Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control 0 1 JJH · Clinical Sample Concentrator 0 1 JSP · Kit, Anaerobic Identification 0 1 JST · Kit, Fastidious Organisms 0 1 JTO · Discs, Strips And Reagents, Microorganism Differentiation 0 1 JTS · Stains, Microbiologic 0 1
All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 46 matching records Device / record Company in FDA record Source Source date ETEST Benzyl Penicillin PG256 FOAM packaging, Product Name: Etest Benzylpenicillin PG 0.016-256 (high).
ETEST is a quantitative technique for det… Z-1527-2017 · JWYBioMerieux SA Recall Mar 21, 2017FDA classification date ETEST Fosfomycin FM1024 Blister packaging, Product Name: ETEST Fosfomycin FM 0.064-1024.
ETEST is a quantitative technique for determining the an… Z-1528-2017 · JWYBioMerieux SA Recall Mar 21, 2017FDA classification date ETEST Imipenem IP32 Foam packaging, Product Name: ETEST Imipenem IP 0.002-32.
ETEST is a quantitative technique for determining the antimicrobial… Z-1529-2017 · JWYBioMerieux SA Recall Mar 21, 2017FDA classification date ETEST Gentamicin GM256 FOAM packaging, Product Name: ETEST Gentamicin GM 0.016-256(low).
ETEST is a quantitative technique for determining the an… Z-1530-2017 · JWYBioMerieux SA Recall Mar 21, 2017FDA classification date ETEST Tobramycin TM256 FOAM packaging, Product Name: ETEST Tobramycin TM 0.016-256(low).
ETEST is a quantitative technique for determining the an… Z-1531-2017 · JWYBioMerieux SA Recall Mar 21, 2017FDA classification date ETEST Ceftriaxone TXL32 FOAM packaging, Product Name: ETEST Ceftriaxone TX 0.002-32(low).
ETEST is a quantitative technique for determining the a… Z-1532-2017 · JWYBioMerieux SA Recall Mar 21, 2017FDA classification date VIDAS Estradiol II, Ref 30431-01, 60 tests
The VIDAS Estradiol II (E2 II) assay is intended for use on the instruments of the VIDAS family (VITEK… Z-1801-2017 · CHPBioMerieux SA Recall Mar 20, 2017FDA classification date NucliSENS Lysis Buffer, REF 200292
NucliSENS Lysis Buffer is intended to be use for the release of total nucleic acid from biological specimens Z-1713-2017 · PPMBioMerieux SA Recall Mar 19, 2017FDA classification date ETEST XM256 (Cefuroxime), Foam: 506958-506918; SPB: 412304-412305
ETEST is a quantitative technique for determining the antimicrobial susceptibi… Z-1226-2017 · JWYBioMerieux SA Recall Feb 21, 2017FDA record creation date VIDAS 3 software v. 1.1.4 Z-1200-2017 · LFZBioMerieux SA Recall Feb 14, 2017FDA classification date MagSIL (NucliSENS easyMAG Magnetic Silica),
Product Usage:
The NucliSENS easyMAG system is an in vitro diagnostic medical device and is intende… Z-0976-2017 · PPMBioMerieux SA Recall Jan 13, 2017FDA classification date NucliSENS magnetic extraction reagents, For in vitro diagnostic use,
Product Usage:
NucliSENS miniMAG is intended to be used for the extraction… Z-0977-2017 · PPMBioMerieux SA Recall Jan 13, 2017FDA classification date NucliSENS easyMAG Magnetic Silica
The NucliSENS easyMAG accessory products are reagents and disposable to be used with the bioMerieux extraction… Z-2342-2016 · LDTBioMerieux SA Recall Aug 9, 2016FDA classification date API ZYM Bx2 (Ref 70493)
Product Usage:
ZYM B reagent is an additional test used for revealing the results of some miniaturized biochemical test … Z-0756-2016 · LIBBioMerieux SA Recall Feb 4, 2016FDA classification date Etest Cefotaxime CT 256 WW and Etest Cefotaxime CT 256 US. in vitro diagnostic. Z-1947-2015 · JWYBioMerieux SA Recall Jul 1, 2015FDA classification date VIDAS D-Dimer Exclusion II, an automated quantitative test for use on instruments of the VIDAS family for the immunoenzymatic determination of fi… Z-2232-2014 · DAPBioMerieux SA Recall Aug 14, 2014FDA classification date VIDAS TPSA, in vitro diagnostic, for use as an automated quantitative measurement of prostate specific antigen levels in human serum or plasma. Z-2152-2014 · MTFBioMerieux SA Recall Aug 6, 2014FDA classification date ZYM B Reagent (REF 70493).
The ZYM B reagent is an additional test used to reveal the results of some miniaturized biochemical test included in … Z-1475-2014 · LIBBioMerieux SA Recall Apr 18, 2014FDA classification date FB Reagent (REF 70562).
FB reagent is an additional test used for revealing the results of some miniaturized biochemical test included in the AP… Z-1476-2014 · LIBBioMerieux SA Recall Apr 18, 2014FDA classification date API NIH (REF 10400).
ZYM B reagent is used and included inside of API NH (REF 10400) and API Listeria (10300). All of the API's are standardized… Z-1477-2014 · LIBBioMerieux SA Recall Apr 18, 2014FDA classification date API Listeria (REF 10300).
ZYM B reagent is used and included inside of API NH (REF 10400) and API Listeria (10300). All of the APIs are standard… Z-1478-2014 · LIBBioMerieux SA Recall Apr 18, 2014FDA classification date
Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗